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Abstract
Mesenchymal stem cells (MSCs) can be induced towards 
chondrogenesis through the application of chondrogenic 
stimuli such as transforming growth factor-β (TGF-β) or 
by multiaxial mechanical load. Previous work has showed 
that the chondrogenic effect of multiaxial load on MSCs 
is mediated by the endogenous production of TGF-β1 
by stimulated cells. This work compared the effects of 
TGF-β1 stimulation and multiaxial mechanical load on 
the secretomes of stimulated cells. MSCs were seeded into 
fibrin-poly(ester-urethane) scaffolds and chondrogenically 
stimulated with either TGF-β1 or mechanical load. 
The culture media was collected and analysed for 174 
proteins using a cytokine antibody array. The results of 
the secretome analysis were then confirmed at a gene 
expression level by real-time PCR. As results implicated 
nitric oxide (NO), the media nitrite content was also 
determined as an indirect measurement of media NO levels. 
Results showed that TGF-β1 stimulation and mechanical 
load lead to similar changes in factors such as BLC, VEGF 
and MMP13, whilst differences in detected levels were 
seen for factors including leptin, MDC, MIP3α and LAP. 
Gene expression analysis confirmed significant changes 
in four factors: angiopoietin 2, GROα, MMP13 and 
osteoprotegerin. After one week in culture the media nitrite 
content was significantly higher in loaded groups than 
both control and TGF-β1 stimulated groups, suggesting 
this may be a major therapeutic target. These data show 
that despite clear similarities, TGF-β1 stimulation and load 
have distinct effects on MSCs and are not analogous. This 
study has identified a number of potentially novel targets 
for tissue engineering, these data may also be useful for 
improving rehabilitation protocols e.g. after microfracture.
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ALCAM – Activated leukocyte cell adhesion molecule
αMEM – Alpha minimal essential medium
BLC – B lymphocyte chemoattractant
BMP – Bone morphogenic protein
DMEM – Dulbecco’s modified Eagle medium
DR6 – Death receptor 6
FBS – Foetal bovine serum
GRO – Growth related oncogene
hBMSC – Human bone marrow derived stem cell
LAP – Latency associated peptide
MDC – Macrophage derived chemokine
MIF – Macrophage migration inhibitory factor
MIP3α – Macrophage inflammatory protein 3 alpha
MMP13 – Matrix metalloproteinase 13
MSC – Mesenchymal stem cell
NO – Nitric oxide
OPG – Osteoprotegerin
PCR – Polymerase chain reaction
PDGF – Platelet derived growth factor
TGF-β – Transforming growth factor beta.
TIMP – Tissue inhibitor of metalloproteinase
uPAR – Urokinase receptor
VEGF – Vascular endothelial growth factor
Introduction
Currently, standard protocols for the induction of 
chondrogenesis in human mesenchymal stem cells (MSCs) 
in vitro involve the culture of cells in a 3D environment 
(e.g. in a pellet/micromass culture or encapsulated with 
in a hydrogel) coupled with the exogenous application of 
an isoform of TGF-β (Barry et al., 2001; Johnstone et al., 
1998). This chondrogenic response is induced by TGF-β 
and mediated by SMAD signalling proteins, which results 
in an increase in the expression of chondrogenic markers 
such as the transcription factor Sox9 and the matrix 
molecules aggrecan and type II collagen (Furumatsu et 
al., 2005; Hellingman et al., 2011; Johnstone et al., 1998). 
Following chondrogenesis, both in vitro (Johnstone et al., 
1998) and in vivo (Mueller and Tuan, 2008), MSCs have 
a tendency to progress towards hypertrophy, which is 
marked by the expression of molecules such as collagen 
type X and MMP13 (D’Angelo et al., 2001; D’Angelo 
et al., 2000; Johansson et al., 1997). This progression 
of MSCs from a cartilage producing phenotype into a 
hypertrophic phenotype is reminiscent of the behaviour 
of mesenchymal progenitor cells during bone formation 
through endochondral ossification and presents a major 
barrier to the use of MSCs for the clinical repair of cartilage 
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tissue (Goldring et al., 2006; Mackie et al., 2011; Mueller 
and Tuan, 2008; Sheehy et al., 2015).
 Previous work has shown that chondrogenesis of human 
bone marrow derived MSCs can be induced in the absence 
of exogenous recombinant TGF-β through the application 
of multiaxial load (Li et al., 2010b; Schatti et al., 2011). 
In this system multiaxial load refers to a combination of 
shear and compression, which mimics the loading of a 
diarthrodial joint in vivo (Grad et al., 2005; Wimmer et al., 
2004). This combination of mechanical stimuli provides 
an in vitro model for studying the response of constructs 
designed to facilitate cartilage repair in a simulated 
joint mechanical environment. Further investigation 
showed that the induction of chondrogenesis in this 
system is linked to the TGF-β signalling pathway (Li et 
al., 2010a). The application of multiaxial load to MSCs 
seeded within fibrin-poly(ester-urethane) scaffolds leads 
to the endogenous production of TGF-β1 by the cells, 
which then drives the chondrogenesis of cells within the 
scaffold. Blocking TGF-β receptor 1 signalling prevents 
this induction of chondrogenesis in response to multiaxial 
mechanical load, showing that the endogenously produced 
TGF-β1 acts through TGF-β1R to induce chondrogenesis 
in response to load (Li et al., 2010a). However, it is 
not currently clear if load induced chondrogenesis is 
exclusively TGF-β mediated.
 MSCs are known to respond to specific stimuli 
by generating matrix molecules and adopting cellular 
characteristics associated with tissues such as bone, 
cartilage and adipose. In addition to these matrix 
molecules, MSCs also secrete a large number of bioactive 
factors (Caplan, 2007; Czekanska et al., 2014). These 
factors provide information on the phenotype of the cells 
producing them, as well mechanistic information about 
changes that occur in cells in response to certain stimuli. 
Crucially, a cell’s secretome provides an indication of 
what effect the cell might have on endogenous cells in a 
clinical situation. The secretomes of MSCs are increasingly 
being studied (Stoddart et al., 2015) and the secretomes of 
MSCs from various sources have been investigated in a 
number of culture conditions in recent years (Haynesworth 
et al., 1996; Kinnaird et al., 2004; Liu and Hwang, 2005; 
Rehman et al., 2004; Sze et al., 2007). These studies have 
focused on different aspects of MSC biology including; 
angiogenesis, myogenesis and osteogenesis (De Lisio 
et al., 2014; Hoch et al., 2012; Oskowitz et al., 2011). 
A number of papers have also investigated the effects of 
chondrogenic stimulation on the MSC secretome (Arufe 
et al., 2011; Bara et al., 2014; Grassel et al., 2009; Rocha 
et al., 2014; Rodriguez et al., 2015). These studies have 
demonstrated the upregulation of factors such as VEGF, 
MMP13 and TIMP1 and 2. To the authors knowledge, 
no investigations have been made into the secretome of 
MSCs undergoing chondrogenesis in response to multiaxial 
load, or compared the secretomes of MSCs responding to 
mechanical load and TGF-β1 stimulation.
 The aim of this study was to compare the secretomes 
of unstimulated hBMSCs, hBMSCs cultured with TGF-β1 
in order to induce chondrogenesis, and hBMSCs cultured 
in the absence of TGF-β1 but with multiaxial mechanical 
load in order to induce chondrogenesis. An early time 
point was investigated as it is relevant during the period 
of cell engraftment and the initiation of healing. It was 
hypothesised that by analysing the secretomes of MSCs 
cultured in different chondrogenic culture conditions, and 
in different mechanical environments, it would be possible 
to compare the effects of mechanical load and TGF-β1 
stimulation on the chondrogenic induction of hBMSCs 
in order to gain greater understanding of the response of 
cells to these two different stimuli. This knowledge could 
also be used to identify interesting and potentially novel 
factors for MSC based tissue engineering.
Materials and Methods
MSC isolation, culture and scaffold seeding
MSCs were harvested from bone marrow aspirates 
collected during routine operations with full-ethical 
approval (KEK-ZH-NR: 2010-0444/0). Mononuclear cells 
were isolated from whole bone marrow of three donors 
(males aged 22, 38 and 77 years old) collected from 
vertebral bodies using a Ficoll density separation method 
(Histoplaque-1077, Sigma-Aldrich, Buchs, Switzerland). 
Mononuclear cells were then seeded at a density of 50,000 
cells/cm2 and left to attach for 96 h in expansion medium 
consisting of alpha Minimum Essential Medium (αMEM) 
(Gibco, Carlsbad, USA), 10 % MSC screened foetal 
bovine serum (FBS) (Pan Biotech, Aidenbach, Germany), 
5 ng / mL basic fibroblast growth factor (bFGF) (Peprotech, 
Rocky Hill, USA) and 1 % penicillin/streptomycin (Gibco, 
Carlsbad, CA). Passage 1 MSCs were frozen and stored in 
liquid nitrogen. Proliferation of MSCs after storage was 
carried out using αMEM 10 % FBS with 5 ng / mL bFGF. 
Passage 3 or 4 cells were seeded into 8 mm × 2 mm fibrin-
poly(ester-urethane) scaffolds (fibrin from Baxter, Vienna, 
Austria) as previously described (Li et al., 2009). Briefly, 2 
million MSCs per scaffold were resuspended in 37.5 µL of 
fibrin (33 mg/mL). The fibrin/cell mixture was then mixed 
with 37.5 µL of thrombin (0.5 U/mL) before being infused 
in to a poly(ester-urethane) sponge and then left at 37°C 
90 % humidity and 5 % CO2 to cure.
Culture conditions
Three different culture conditions were used for this 
experiment. Constructs were either cultured in a free 
swelling environment with chondropermissive medium 
(consisting of Dulbecco’s modified Eagle medium 4.5 g/L 
glucose (Gibco, Carlsbad, USA), sodium pyruvate 0.11 g/L 
(Sigma-Aldrich, Buchs, Switzerland), L-ascorbic acid 
2-phosphate sesquimagnesium salt hydrate 50 μg/mL 
(Sigma-Aldrich, Buchs, Switzerland), dexamethasone 
1 × 10-7 M (Sigma-Aldrich, Buchs, Switzerland), insulin 
transferrin and selenium 1 % (Cyangen, Guangzhou, 
China), Non-essential amino acids 1 % (Gibco, Carlsbad, 
USA), Primocin 0.1 % (Invitrogen, San Diego, USA) 
and 6-aminocaproic acid 5 μM (Sigma-Aldrich, Buchs, 
Switzerland) to prevent fibrin degradation (Kupcsik et al., 
2009), a free swelling environment with chondropermissive 
medium supplemented with 1 ng/mL active TGFβ1 
(Fitzgerald, Acton, USA), or with exposure to multiaxial 
loading in TGFβ free chondropermissive media. A 
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concentration of 1 ng/mL was chosen for the TGF-β1 
stimulated group as media collected from mechanically 
loaded scaffolds consistently contain approximately 1 ng/
mL of endogenously produced TGF-β1 (Li et al., 2010a). 
The medium was refreshed on day 2, 4 and 6.
Mechanical loading
Multiaxial shear (± 25 at 1 Hz) and compression (10 % 
compression superimposed on top of a 10 % pre-strain 
at 1 Hz) loading was applied for one hour a day six times 
over 8 d (on days 2-7) (Li et al., 2010a).
Sample collection
The work presented here represents data from two sets of 
experiments, each with the same experimental design. The 
first set of experiments consisted of three biological repeats, 
each using MSCs from a different donor (donors were aged 
22, 27 and 77 y). In the first set of experiments the culture 
media were collected on day 2, 4, 6 and 8 for TGF-β1 
quantification and secretome analysis. The second set of 
experiments was performed in order to collect additional 
data to supplement and confirm the results of the first set 
of experiments. This second set of experiments replicated 
the first, using cells from the same three MSC donors as 
the first experiment with the same passage number at the 
time of seeding. Culture media were collected on day 2, 4, 
6 and 8 for nitrite quantification and on day 8 the scaffolds 
were homogenised in TRI reagent (Molecular Research 
Centre Inc., Cincinnati, OH, USA) and stored at −80°°C 
for RNA isolation and real-time PCR analysis.
Culture media analysis
Media collected on day eight of culture were further 
analysed to determine the presence of 174 different 
cytokines within each sample using the RayBio Human 
Cytokine Antibody Array G-Series 2000 protein array 
according to the manufacturer’s instructions, for relevant 
abbreviations see Table 1. The slides were sent to THP 
Medical Products Vertreibs Gmbh (Vienna, Austria) for 
analysis.
 The total amount of TGF-β1 in the culture media 
collected between day 2 and day 8 was determined using 
the human TGF-beta 1 DuoSet ELISA (R&D systems, 
Minneapolis, USA) according to the manufacturer’s 
instructions
 The Griess reaction to detect nitrite in collected culture 
media was performed using Griess reagent (modified) 








Factors with a Significant Difference in One Comparison
Leptin Low 0.0246 0.4757 0.6992
Leptin receptor Low 0.0144 0.9999 0.1721
Macrophage derived chemokine (MDC) Very Low 0.0378 0.3897 0.9813
Chemokine (CC motif) ligand 20 (CCL20), macrophage inflammatory 
protein 3 α (MIP3α) Very Low 0.2550 0.032 0.9999
Chemokine (CXC motif) ligand 1,2 and 3 (CXCL1,2 and 3), Growth 
related oncogene α, β and γ (GROα, β and γ) Moderate-High 0.0749 0.0272 0.9999
Urokinase receptor (uPAR) Low 0.1820 0.0358 0.9999
Latency associated peptide (LAP) Moderate 0.1968 0.0001 0.0667
Angiogenin High-Very High 0.0526 0.0019 0.8959
Angiopoietin 2 (ANG2) High 0.7034 0.1869 0.0061
Osteoprotegrin (OPG) Moderate-High 0.9999 0.1573 0.0113
Tumour necrosis factor receptor superfamily 21 (TNFRSF21), death 
receptor 6 (DR6) Low-Moderate 0.4128 0.8959 0.0348
Factors with a Significant Difference in Two Comparisons
Transforming growth factor β 1 (TGF-β1) Low 0.0157 0.9999 0.0411
Cluster of differentiation 166 (CD166), activated leukocyte cell adhesion 
molecule (ALCAM) Low 0.9999 0.0226 0.0378
Chemokine (CXC) motif ligand 13 (CXCL13), B lymphocyte 
chemoattractant (BLC) Low-Moderate 0.032 0.0002 0.4884
Chemokine (CC motif) ligand 7 (CCL7), Monocyte specific chemokine 
3 (MCP3) Low 0.0012 0.0089 0.9999
Macrophage migration inhibitory factor (MIF) High 0.0328 0.0001 0.2883
Vascular endothelial growth factor (VEGF) Moderate-High 0.0091 0.0091 0.9999
Matrix metalloproteinase 13 (MMP13), collagenase 3 Low-Moderate 0.0189 0.0010 0.9999
Platelet derived growth factor AA (PDGFAA) Low 0.004 0.0055 0.9999
Table 1. The results of statistical comparisons made between groups. All factors that showed at least one significant 
change are included. A p-value displayed in red represents a decrease in expression in the group the comparison was 
made to (e.g. a red p-value in the ‘TGF-β1-load’ column indicates a decrease in the TGF-β1 stimulated group compared 
to the loaded group) whilst green represents an increase in expression in the group the comparison was made to (e.g. a 
green p-value in the ‘TGF-β1-control’ column indicates an increase in the TGF-β1 stimulated group compared to the 
control group). Abundance demonstrates the overall amount of protein in the medium based on the strength of signal 
detected during measurement, this is only arbitrary and acts as a general indicator of the amount of a particular protein 
relative to the others detected (the units are arbitrary and represent fluorescence intensity, Very low < 100, low 100-500, 
moderate 500-1000, high 1000-4000 and very high > 4000).
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Briefly, 100 µL of Griess reagent was added to 100 µL 
of standards and samples. The reaction was allowed to 
proceed for 15 min in the dark before the absorbance was 
measured at 530 nm.
Reverse transcription and real-time PCR
Total RNA was isolated on day 8 from samples in TRI 
reagent as per the manufacturer’s instructions. Reverse 
transcription was performed using random hexamer 
primers and TaqMan reverse transcription reagents 
(Applied Biosystems, Carlsbad, CA, USA).
 Real-time PCR was performed using the applied 
biosciences StepOnePlus real-time PCR system (Applied 
Biosystems, Carlsbad, CA, USA). Primers for VEGF 
mRNA were synthesised by Microsynth AG (Balgach, 
SG, Switzerland). Primers for angiogenin, angiopoietin 
2, BLC, GROα, leptin, MCP3, MIF, MIP3α, MMP13, 
osteoprotegerin, PDGFA and ribosomal 18s RNA were 
purchased from Applied Biosystems, Switzerland. The 
level of gene expression for each gene was determined 
relative to 18s rRNA using a ΔΔCT comparison.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 
6 software (GraphPad Software Inc., La Jolla, USA). 
Results of TGF-β1 quantification and secretome analysis 
represent data from three different MSC donors with each 
group containing three technical repeats. Results of nitrite 
quantification and real-time PCR analysis represent data 
from three biological repeats, with each group containing 
four technical repeats.
 The fluorescent intensity levels recorded for each 
sample from the cytokine array were adjusted to remove 
background interference. Outliers were then removed 
using the ROUT method, normality was determined using 
the D’Agostino-Pearson omnibus normality test and the 
statistical difference was then determined between control 
and TGF-β1 cultured groups, between load and control and 
between load and TGF-β1 cultured groups using Kruskal-
Wallis test and Dunn’s multiple comparison test.
 The results of TGF-β1 quantification, nitrite 
quantification and real-time PCR analysis were tested 
for normality using the D’Agostino-Pearson omnibus 
normality test. Statistical differences of media TGF-β1, 
nitrite ions and all genes analysed by real-time PCR (except 
leptin and MMP13) were determined using the Kruskal-
Wallis test and Dunn’s multiple comparison test. Statistical 
significance for leptin and MMP13 was determined using 




On day 2 the amount of TGF-β1 measured in the culture 
medium of TGF-β1 stimulated scaffolds was higher than 
both control and loaded groups (p = 0.0378) (Fig. 1A). 
This was expected, as the TGF-β1 cultured group was 
receiving TGF-β in the media at this point whilst the 
other two groups were not. At day 4 of culture (Fig. 1B), 
as mechanical loading began to induce the production of 
TGF-β1 by the cells within the scaffold, the amount of 
TGF-β1 in the media collected from TGF-β1 stimulated 
scaffolds was significantly higher than that of the control 
group (p = 0.0017) but not significantly different from the 
loaded group. By day 6 of culture, multiaxial mechanical 
loading had led to a significant increase in TGF-β1 
production compared to control scaffolds and the level 
of TGF-β1 in the media of both TGF-β1 stimulated and 
loaded groups was significantly higher than that of the 
control group (p = 0.0001 and 0.0207 respectively). 
Both TGF-β1 stimulated and load media also contained 
significantly more TGF-β1 than control samples on day 
eight (p = 0.0002 and 0.0060 respectively).
Cytokine detection
All 174 factors were detected at varying levels of intensity 
in all samples. An average fluorescence intensity value was 
calculated for each factor at day 8 from all three conditions 
(control, load and TGF-β1 stimulated) in order to provide 
a guide to the level of detection of the different factors 
across the groups, rather than in specific conditions. 55 
factors had an average fluorescence intensity across the 
three groups of less than 100 including; leptin (93.79 
± 81.83) and MDC (54.81 ± 9.98). The average intensity 
of 94 factors was between 100 and 500 including; BLC 
(389.19 ± 557.10), MCP3 (201.30 ± 115.94), ALCAM 
(141.57 ± 37.54), uPAR (286.63 ± 109.39), leptin receptor 
(110.07 ± 29.35), MMP13 (422.77 ± 512.66) and PDGFaa 
(171.75 ± 76.35). The intensity of 11 factors was between 
500-1000 including; osteoprotegerin (986.16 ± 560.48) 
and VEGF (938.11 ± 397.31). 12 factors had an average 
intensity between 1000 and 4000 including; angiopoietin-2 
(1341.87 ± 937.81), GRO (1326.36 ± 1011.64) and LAP 
(1302.15 ± 752.86). The intensity of two factors was 
above 4000; angiogenin (40273.68 ± 7037.95) and TIMP2 
(6778.68 ± 2231.98). The factor with the highest recorded 
intensity, by a factor of 10, was angiogenin and the lowest 
was BMP6 (20.50 ± 18.21).
 For each of the 174 factors analysed, three sets of 
comparisons were performed (between control and 
TGF-β stimulated scaffolds, control and loaded scaffolds 
and TGF-β1 stimulated and loaded scaffolds) and the 
significance of statistical differences between the groups 
determined. Analysis showed that 19 factors changed 
significantly in at least one of these comparisons. The three 
volcano plots in Fig. 2 graphically represent the results of 
these three comparisons. These plots were produced by 
plotting the Log10 of the fold change for a factor between 
one condition and another (e.g. control and TGF-β1) on the 
X-axis, against the −Log10 of the p-value generated when 
testing the difference between the two conditions on the 
Y-axis. Therefore, the further a factor is away from zero 
on the X-axis the greater the fold change up or down. The 
further a factor is up the Y-axis the lower the p-value, a 
p-value of 0.05 equates to 1.30 on the Y-axis. Therefore, 
any factors above this value underwent a significant 
change.
 Fig. 2A shows a volcano plot generated based on 
the comparison between media conditioned by TGF-β1 
stimulated scaffolds and control medium, factors that 
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Fig. 1. Quantification of total TGF-β1 in the 
culture media of control, TGF-β1 stimulated 
and loaded scaffolds by week, over four weeks 
of culture. Statistical significance was defined 
as p ≤ 0.05 and determined using the Kurskal-
Wallis and Dunn’s multiple comparison tests. * 
represents p ≤ 0.05, ** represents p ≤ 0.001 and 
*** represents p ≤ 0.0001.
Fig. 2. Volcano plots showing the results of the three sets of 
statistical comparisons made between groups. These plots 
have −Log10 p-value of the comparison on the Y-axis and 
Log10 fold change of the comparison for each factor on the 
X-axis. As a result the greater the fold change the further 
a factor is away from zero on the X-axis and the lower 
the p-value of a comparison the further away from zero 
on the Y-axis. Factors that underwent a significant change 
have been labelled. The red line on the Y-axis represents 
a −Log10 p-value of 1.3 this is equivalent to a p-value of 
0.05, factors above this line underwent a significant change.
Plot A. represents TGF-β1 stimulated samples compared 
to controls. Factors on the left-hand side of the Y-axis 
were higher in controls than TGF-β1 stimulated samples 
and factors on the right-hand side were higher in TGF-β1 
stimulated samples than controls.
Plot B. represents loaded samples compared to controls. 
Factors on the left had side of the Y-axis were higher in 
controls than loaded samples and factors on the right hand 
side were higher in loaded samples than controls.
Plot C. represents TGF-β1 stimulated samples compared to 
loaded samples. Factors on the left hand side of the Y-axis 
were higher in loaded samples than TGF-β1 stimulated 
samples and factors on the right hand side were higher in 
TGF-β1 stimulated samples than loaded samples.
226 www.ecmjournal.org
OFW Gardner et al.                                                                                              MSC secretome during chondrogenesis
appear on the left side of the Y-axis were detected at a 
higher level in control medium, and factors on the right 
hand side of the axis at a higher level in TGF-β1 stimulated 
medium. Factors which are significantly different between 
control and TGF-β1 stimulated medium have been labelled. 
Fig. 2B shows a volcano plot constructed in the same way 
as Fig. 2A, using data from the comparison between control 
medium and medium conditioned by cells exposed to 
multiaxial load. Factors that appear on the left side of the 
Y-axis were detected at a higher level in control medium 
and factors on the right hand side of the axis at a higher 
level in medium from loaded samples.
 The volcano plots for control-TGF-β1 media and 
control-load media show both similarities and differences 
between the effects of load and TGF-β1 stimulation 
compared to control conditions. In medium conditioned 
by both TGF-β1 stimulated and loaded scaffolds there was 
a significant upregulation (found on the right hand side of 
the Y-axis and above 1.30 on the Y-axis) of BLC, MCP3, 
MIF, VEGF, MMP13 and PDGFaa compared to control 
(Fig. 2A&B). No factors were significantly down regulated 
in both TGF-β1 stimulated and loaded groups compared 
to controls. Leptin, leptin receptor and MDC were 
upregulated in medium from TGF-β1 stimulated scaffolds 
Fig. 3. Box plots showing the results of cytokine antibody array analysis. This figure contains the 19 factors that showed 
a significant change between in at least one comparison (the three comparisons were between control and TGF-β1, 
between load and controls and load and TGF-β1). Statistical significance was defined as p ≤ 0.05 and determined 
using the Kurskal-Wallis and Dunn’s multiple comparison tests. * represents p ≤ 0.05, ** represents p ≤ 0.001 and 
*** represents p ≤ 0.0001.
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compared to controls but did not change in medium from 
loaded scaffolds compared to controls. MIP3α, uPAR, LAP 
and angiogenin were detected at significantly levels in 
response to load compared to control, but did not change 
in TGF-β1 compared to controls, whilst the concentration 
of GRO was significantly lower in response to load but did 
not change significantly in response to TGF-β1 stimulation.
 The third volcano plot (Fig. 2C) shows the results of a 
direct comparison between media from TGF-β1 stimulated 
scaffolds and loaded scaffolds. In this plot, factors detected 
at a higher level in media collected from loaded scaffolds 
are found on the left hand side of the Y-axis and factors 
found at a higher level in media from TGF-β1 stimulated 
scaffolds are found on the right hand side of the Y-axis. This 
plot clearly shows that the majority of factors measured 
were found at a higher level in the media collected from 
loaded scaffolds. Angiopoietin 2, osteoprotegerin, ALCAM 
and DR6 were found at higher levels in loaded media than 
TGF-β1 stimulated media whilst TGF-β1 was found at 
higher levels in TGF-β1 stimulated medium than loaded 
medium.
 The comparisons made between the three groups 
have been provided in the form of box plots (Fig. 3) as 
well as in the volcano plots (Fig. 2) in order to display 
the results in a factor by factor manner. Six factors (BLC, 
MCP3, MIF, VEGF, MMP13 and PDGFaa) were found 
to change significantly in both TGF-β1 and loaded groups 
compared to controls. In all of these cases the factors 
were significantly higher in TGF-β1 and loaded groups 
than controls (Table 1, Fig. 3D, J, L, N, P and Q). The 
similarities in the responses of these factors indicate 
similarities in the effects of these two forms of stimulation, 
potentially due to the effect of TGF-β1 signalling in both 
systems.
 ALCAM was significantly increased in the loaded 
group over both control and TGF-β1 stimulated groups 
showing a clear difference in effect between load and 
TGF-β1 stimulation (Table 1, Fig. 3A).
 Table 2 provides information on the interactions that are 
described in the literature between the factors that changed 
significantly in this study with/on cartilage/chondrogenesis.
Real-time PCR gene expression analysis
Real-time PCR was performed in order to determine the 
relative gene expression levels of factors that demonstrated 
significant changes between groups in the secretome 
analysis. Of the 19 factors that underwent significant 
changes, 9 were chosen for real-time PCR analysis 
based on their expression as soluble and not membrane 
bound proteins, and evidence for a potential link to 
Factor name Known links to chondrogenesis/cartilage References
Leptin Localised to the growth plate and osteoarthritic cartilage. Knock out 
mice have disrupted growth plates. Leptin induces GAG loss from 
cartilage plugs and activates MMPs.
(Dumond et al., 2003; Hui et al., 2012; Iliopoulos 
et al., 2007; Kishida et al., 2005; Kume et al., 
2002; Zeddou et al., 2012)
Leptin Receptor Localised the growth plate and to osteoarthritic cartilage. Expressed by 
chondrocytes in monolayer culture.
(Kishida et al., 2005; Ohba et al., 2010; 
Simopoulou et al., 2007) 
MDC Expressed in the synovial tissue of arthritic joints. (Flytlie et al., 2010)
MIP3α Induced MMP13 expression in articular chondrocytes in monolayer 
culture. Increased levels found in rheumatic joints.
(Lisignoli et al., 2006; Mazzetti et al., 2004)
GRO Found in arthritic joint and expressed by normal chondrocytes. Capable 
of inducing hypertrophy in chondrocytes in vitro.
(Chen et al., 2013a; Merz et al., 2003; Olivotto et 
al., 2007; Wenke et al., 2011)
uPAR Capable of activating MMPs and associated with plasmin, an activator 
of TGF-β.
(Beaufort et al., 2004; Blasi and Carmeliet, 2002; 
Montuori et al., 2005; Schwab et al., 2004)
LAP Released during TGF-β activation. (Maeda et al., 2002)
Angiogenin Found in diseased and arthritic joints. (Liote et al., 2003) 
Angiopoietin 2 Destabilises blood vessel formation by acting as a TIE2 antagonist. (DeBusk et al., 2003; Horner et al., 2001)
Osteoprotegerin Found in normal and arthritic cartilage. Chondroprotective in a murine 
OA model.
(Komuro et al., 2001; Shimizu et al., 2007)
DR6 - -
TGF-β Induces chondrogenesis in mesenchymal stem cells. (Johnstone et al., 1998)
ALCAM Used to identify chondroprogenitor cells. Expressed by chondrocytes 
from diseased and normal joints.
(Alsalameh et al., 2004; Arai et al., 2002; Chen et 
al., 2013b)
BLC Expressed by chondrogenically differentiated MSCs. BLC 
neutralisation reduced the severity within a murine autoimmune 
arthritis model.
(Cristino et al., 2008; Zheng et al., 2005)
MCP3 - -
MIF Detected in RA joints and associated with inflammation and MMP 
expression. Neutralisation reduced the severity of a murine autoimmune 
arthritis model.
(Morand and Leech, 2005; Santos et al., 2001)
VEGF Expressed by normal and hypertrophic chondrocytes. Important in 
hypertrophy, chondrocyte specific inactivation leads to failed endo-
chondral ossification.
(Bluteau et al., 2007; Dai and Rabie, 2007)
MMP13 Involved in cartilage turnover and acts as a marker of MSC and chon-
drocyte hypertrophy.
(Mueller and Tuan, 2008)
PDGF Important in chondrogenesis during development. (Ataliotis, 2000)
Table 2. The factors identified by this work as undergoing a significant change in media content in response to load or 
TGF-β1 stimulation and a description of their known links to cartilage/chondrogenesis.
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chondrogenesis, hypertrophy or mechanical load in the 
literature. Membrane bound proteins were not analysed 
as changes in receptor turnover and shedding mean that 
comparison between media protein levels and mRNA 
levels difficult to reconcile. The factors were; angiogenin, 
angiopoietin 2, GROα, leptin, MIF, MMP13, OPG, PDGFa 
and VEGF.
 Results of real-time PCR for angiopoietin 2 and 
osteoprotegerin show that as in the secretome analysis the 
expression in the TGF-β1 group is significantly lower than 
in the loaded group, in the PCR analysis the expression 
level is also seen to be lower in the TGF-β1 stimulated 
group than in control scaffolds (Fig. 4B and G). The 
expression of MMP13 was normalised to the control group 
as the expression of MMP13 in cells at day 0 was donor 
dependent. Real-time PCR shows that the expression of 
MMP13 is similar in TGF-β1 stimulated and loaded groups 
and that also the expression in both groups is much higher 
than control groups (Fig. 4F). The expression of GRO 
was also lower than controls in both stimulated groups 
(Fig. 4C), although not as strongly as suggested by the 
secretome data or other results collected by this group 
(data not shown).
 Secretome analysis showed that leptin was detected at 
a higher level in media from TGF-β1 stimulated scaffolds 
than control samples, whilst angiogenin was detected at 
a higher level in loaded samples than controls (Fig. 3B 
and H). For both of these factors real-time PCR analysis 
showed no difference between stimulated groups in the 
case of leptin (which as with MMP13 was normalised to 
the control groups due to donor dependent expression at 
day 0) or stimulated groups and controls in the case of 
angiogenin (Fig. 4A and D).
 The results of secretome analysis showed that MIF, 
PDGFaa and VEGF were all detected at higher levels in 
both TGF-β1 stimulated and loaded groups than controls, 
whilst not being significantly different from each other (Fig. 
3L, P and Q). This was not reflected in gene expression 
analysis where neither stimulated group was found to be 
significantly different from controls (Fig. 4E, H and I).
Fig. 4. Box plots showing the results of real-time PCR. This figure contains shows the results of the 12 factors 
investigated, each of which had showed a significant change between in at least one comparison made between groups 
during secretome analysis (the three comparisons were between control and TGF-β1, between load and controls and 
load and TGF-β1). Statistical significance was defined as p ≤ 0.05 and determined using the Kurskal-Wallis and Dunn’s 
multiple comparison tests. * represents p ≤ 0.05, ** represents p ≤ 0.001 and *** represents p ≤ 0.0001.
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Media nitrite quantification
A number of the factors identified by the initial secretome 
analysis are known to respond to shear forces in other 
model systems (angiopoietin-2, PDGF and MCP3). 
Another factor commonly associated with shear loading, 
particularly in vascular cells, is nitric oxide. In order to 
investigate the effect of load on nitric oxide in this system, 
the presence of inorganic nitrite was detected in the culture 
media using the Griess reaction. Results showed that at 
all four time points (day two, four, six and eight) the level 
of nitrites detected in the TGF-β1 stimulated group was 
significantly lower than that of the loaded group, but not 
significantly different from the control group (Fig. 5A, B, 
C and D). There were significantly higher levels of nitrites 
in the culture media of loaded scaffolds compared to both 
control and TGF-β1 stimulated scaffolds on days four, six 
and eight (Fig. 5A, B, C and D). No significant difference 
was detected between loaded scaffolds and controls on 
day 2 (Fig. 5A).
Discussion
Currently accepted methods for the induction of 
chondrogenesis in MSCs use a combination of 3D culture 
and the exogenous administration of an active recombinant 
isoform of TGF-β (Barry et al., 2001; Johnstone et al., 
1998). Recent work has shown that chondrogenesis can 
be induced in MSCs using multiaxial mechanical load 
in the absence of exogenous TGF-β (Li et al., 2010a; 
Li et al., 2010b; Schatti et al., 2011). The purpose of 
this investigation was to compare the secretomes MSCs 
stimulated either with exogenous TGF-β or multiaxial load 
with each other and with unstimulated control scaffolds, 
to highlight similarities and differences between these two 
forms of chondrogenic induction and determine interesting 
or potentially novel factors for MSC based cartilage tissue 
engineering.
 BLC, MCP3, MIF, VEGF, MMP13 and PDGF 
were upregulated in response to both load and TGF-β1 
stimulation and may represent a core of factors that are 
responsive to TGF-β1, which is known to be involved in 
the induction of chondrogenesis in the loaded scaffolds 
as well as the TGF-β1 stimulated scaffolds (Li et al., 
2010a). MMP13 is a well characterised and described 
marker associated with chondrocyte and MSC hypertrophy 
(D’Angelo et al., 2000). The secretion of BLC in to the 
culture media has previously been described on day seven 
of the TGF-β driven chondrogenesis of MSCs. However, 
little information is available to suggest a role for BLC in 
MSC chondrogenesis (Cristino et al., 2008). MCP3 has 
been shown to be induced by TGF-β in fibroblasts in a 
SMAD dependent manner and in response to mechanical 
stimulation in osteocytes (Ong et al., 2009). The production 
of both PDGFaa and VEGF is known to be responsive 
to TGF-β (Jeon et al., 2007; Tanabe et al., 2006; Wang 
et al., 1997). These factors therefore have clear links 
to TGF-β1 or TGF-β1 driven chondrogenesis and this 
may explain the similarities between loaded and TGF-β1 
stimulated scaffolds when compared to control scaffolds. 
The expression of all six of these factors has also previously 
been described in MSCs (Cristino et al., 2008; Grassel et 
al., 2009; Hoch et al., 2012; Kinnaird et al., 2004; Palumbo 
et al., 2014; Rehman et al., 2004; Ribeiro et al., 2012; Sze 
et al., 2007). Some of these factors have also previously 
been associated with similar responses to TGF-β in a 
Fig. 5. Quantification of 
nitrite (as an indirect marker 
measure of nitric oxide (NO)) 
in the culture media of control, 
TGF-β1 stimulated and loaded 
scaffolds by week, over four 
weeks of culture. Statistical 
significance was defined as 
p ≤ 0.05 and determined using 
the Kurskal-Wallis and Dunn’s 
multiple comparison tests. 
* represents p ≤ 0.05, ** 
represents p ≤ 0.001 and *** 
represents p ≤ 0.0001.
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range of cell types e.g. BLC, MCP3, VEGF, MMP13 and 
PDGFaa (Cristino et al., 2008; Fitzgerald et al., 2008; Jeon 
et al., 2007; Ong et al., 2009; Tanabe et al., 2006; Wang 
et al., 1997).
 As well as factors that responded similarly to both 
forms of chondrogenic induction there were a number that 
underwent different responses. Leptin has been localised 
to the synovial fluid of arthritic joints and is found at a 
higher level in cartilage from arthritic joints than normal 
cartilage (Kume et al., 2002). A role for leptin has also been 
suggested in the growth plate where leptin knock out leads 
to disrupted column formation and reduced collagen type 
X production (Kishida et al., 2005). These observations in 
vivo suggest that leptin is involved in hypertrophy and may 
act as a marker of hypertrophy. This is supported by work 
by Iliopoulos et al. (2007), who showed that leptin could 
stimulate MMP13 expression in articular chondrocytes in 
vitro and that siRNA knock down of leptin expression leads 
to a reduction in MMP13 production. This suggests that the 
increase in leptin, in response to TGF-β stimulation, may 
be indicative of a more hypertrophic phenotype than that 
induced by load. However, further work would be required 
to investigate this. Should leptin’s hypertrophic effects on 
MSCs be verified then it would provide and interesting 
avenue for reducing hypertrophy within cartilage tissue 
engineering.
 Little is known regarding the role of or effect on 
chondrogenesis of MDC. However, its expression has been 
detected in the synovial tissue of patients with rheumatic 
and psoriatic arthritis. The presence of MDC in these 
tissues may be due to its role in inflammation and further 
work is required to determine its effect of chondrogenesis 
(Flytlie et al., 2010).
 LAP is released from the mature TGF-β1 peptide during 
activation. Mechanical loading and, in particular, shear 
loading has been shown to activate TGF-β, an effect also 
seen within the bioreactor culture system presented in this 
paper (Paper in review) (Ahamed et al., 2008; Albro et al., 
2012; Annes et al., 2004; Wipff et al., 2007). The increased 
presence of LAP in the culture media of loaded scaffolds 
is, therefore, likely to be due to activation of endogenously 
produced pro-forms of TGF-β.
 The expression of GRO has been detected in 
osteoarthritic chondrocytes, and has is capable of inducing 
the expression hypertrophic markers such as MMP13 and 
collagen type X, as well as mineralisation in chondrocytes 
(Endres et al., 2010; Merz et al., 2003; Olivotto et al., 2007). 
These results suggest that the reduction in GRO expression 
in response to TGF-β1 stimulation and mechanical load 
expression marks an anti-hypertrophic effect. This may 
be an interesting avenue for cartilage repair. Hypertrophy 
is a major bar on the use of MSCs clinically and targeting 
factors such as GRO that are involved in hypertrophy may 
provide ways of circumventing this issue.
 Both angiopoietin-2 and osteoprotegerin have been 
shown to be induced by the application of shear forces 
which may be linked to their increased presence in media 
from loaded scaffolds over TGF-β1 stimulated scaffolds 
(Goettsch et al., 2008; Kim et al., 2006; Li et al., 2014).
 The amount of TGF-β1 detected in the culture media 
by cytokine array was significantly higher at day eight 
in TGF-β1 stimulated samples than both control and 
loaded samples. This is at odds with the result of the 
ELISA quantification of day eight media, which showed 
that there was no significant difference in the media 
TGF-β1 concentration of loaded and TGF-β1 stimulated 
groups. The ELISA data also indicated that both TGF-β1 
stimulated groups and loaded groups were significantly 
higher than the control group on day eight. However, the 
results of the cytokine array also demonstrated that the 
overall fold change between TGF-β1 and load was 1.17 
and between TGF-β1 and control 1.2, suggesting very little 
overall difference the total amounts of TGF-β1 present. 
These changes are lower than the 1.5-fold change used 
by Rodriguez et al. to denote significance and the 2-fold 
change used to class a factor as physiologically relevant 
by Grassel et al. (Grassel et al., 2009; Rodriguez et al., 
2015). This result highlights the fact that this form of 
analysis is extremely valuable for identifying the presence 
of potential factors of interest within samples. But, more 
precise techniques incorporating standard curves, such as 
ELISA, should be performed for absolute quantification.
 Following the results of secretome analysis, this work 
was repeated to confirm that the changes seen at a protein 
level were also detectable at a gene expression level using 
real-time PCR. The results of real-time PCR analysis 
confirmed some of the changes seen in the secretome data 
e.g. for angiopoietin 2 and osteoprotegerin, but did not 
support the changes seen in all the factors e.g. VEGF and 
PDGFa. The detection of similar changes in secretome 
analysis and gene expression suggests that the changes seen 
in these factors are robust; this highlights angiopoietin 2, 
osteoprotegerin, MMP13 and GROa as factors of particular 
interest. The difference in the gene expression and protein 
analysis for these genes may relate to the time points 
of sample collection. The media used for the secretome 
analysis were conditioned between days 6 and 8 of culture, 
whilst the mRNA collection represents a single time point 
on day 8. As a result, the gene expression profiles of these 
factors may have risen and fallen again before the sampling 
on day 8, and may explain the difference in mRNA and 
protein profiles. Alternatively, this may be due to the small 
fold changes seen in the secretome results for these factors, 
which may explain the lack of a significant change in gene 
expression levels despite a statistically significant change 
in the amounts of protein detected.
 Study of the literature associated with the factors 
identified during the secretome analysis highlighted similar 
responses to shear force with regards to factors such as 
angiopoietin-2, PDGF and MCP3 in other cell types and 
model systems. The literature also highlighted the increase 
in nitric oxide (NO) production in response to shear loading 
in endothelial cells in response to mechanical shear forces 
(Bao et al., 1999; Goettsch et al., 2008). In MSCs, NO 
production has previously been shown to be induced in 
response to fluid flow induced shear loading (Knippenberg 
et al., 2005), and also has been shown to play a role in 
MSC immunomodulation through the suppression of the 
T-cell response (Ren et al., 2008; Sato et al., 2007). The 
clear changes in NO production in response to joint-like 
multiaxial load suggest that NO production mechanisms 
could be targeted for therapeutic benefit. This work is 
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the first to implicate NO as a potential influencing factor 
during the multiaxial load applied after marrow stimulation 
techniques (which result in the formation of a fibrin clot 
containing MSCs). NO has been widely linked to arthritis, 
particularly the upregulation of MMPs, matrix degradation 
and the suppression of proteoglycan and collagen synthesis 
(Abramson, 2008). Nitric oxide also has a negative effect on 
TGF-β expression which has leads to a reduction in GAG 
production as a result in the reduction of TGF-β (Studer 
et al., 1999). Previous work in to this area has shown that 
the suppression of nitric oxide synthase (NOS) can reduce 
the severity of symptoms in a murine model of arthritis 
(McCartney-Francis et al., 1993). Therefore, reducing 
the local presence of NO in joints during post-operative 
rehabilitation e.g. after microfracture, could improve the 
outcome of cartilage repair by reducing the effects of NO 
on cartilage matrix synthesis, cartilage degradation and 
TGF-β signalling. However, further work is required to 
identify the role of NO in response to load and the effect 
that it has on MSC chondrogenesis, as NO may play a direct 
role in mechanotransduction and, therefore, the generation 
of cartilage-like repair material in response to joint loading 
in vitro. A clear next step is to establish whether the NO 
plays a role in mechanotransduction, and whether it has 
an inhibitory effect on cartilage tissue development under 
these conditions and the extent to which NO levels can be 
modulated to improve chondrogenic outcomes.
Conclusions
The results of secretome analysis presented here show that 
there are clear similarities and differences between the 
secretomes of MSCs stimulated with multiaxial mechanical 
load or TGF-β1. Nineteen factors were identified by 
secretome analysis as being significantly different in two 
or more groups. Of particular interest are the four factors 
(angiopoietin 2, GROα, MMP13 and osteoprotegerin) 
whose changes in secretome profile between the groups 
were mirrored by their changes in gene expression as 
determined by real-time PCR. Alongside these factors, 
this work identifies for the first time an increase in NO 
production in response to joint stimulating mechanical 
load. These data demonstrate that the chondrogenic 
effects of multiaxial mechanical load and stimulation 
with exogenous TGF-β1 are not analogous. The factors 
identified by this work, and their potential for manipulation, 
presents a multitude of novel and interesting avenues for 
further investigation with regards to mesenchymal stem 
cells and cartilage tissue engineering.
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Discussion with Reviewers
Reviewer I: The discussion about NO is a strong section 
of the paper. However, some of the data indicate that NO 
could be good (inhibiting T-cell response?). Could the NO 
being produced by load be a good not bad thing? This was 
sort of alluded to in mentioning that it could play a role in 
mechanotransduction.
Authors: Further work is required to identify the role 
of NO in response to load and the effect that it has on 
MSC chondrogenesis, as NO may play a direct role in 
mechanotransduction and therefore for the generation of 
cartilage-like repair material in response to joint loading 
in vitro. A clear next step is to establish whether the NO 
plays a role in mechanotransduction, and whether it has 
an inhibitory effect on cartilage tissue development under 
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these conditions and the extent to which NO levels can be 
modulated to improve chondrogenic outcomes.
Reviewer I: One limitation of the study is that the 
secretome is only analysed at a single time point. Clearly 
chondrogenesis is a dynamic process and we would 
anticipate the secretome would change. Furthermore, as 
noted there were instances where protein and gene data 
do not correlate, which (as discussed by the authors) is not 
unreasonable given this dynamic process and other reasons 
for a non-linear correlation between gene and protein. 
Looking forward, how could future experiments address 
the dynamic process of chondrogenesis and hypertrophic 
maturation?
Authors: The question of timing and the change in the 
secretome profile over time is a really important one. This 
study aimed to identify candidate molecules. The follow 
up would be to repeat this experiment with several time 
points (e.g. 3, 7, 14 and 21 days). The candidate molecules 
could then be investigated in more detail with assays such 
as ELISA. Alongside this, follow up studies based on the 
work presented here will allow for the characterisation of 
some of the markers identified in this work. These novel 
markers may also be useful for looking at the process of 
chondrogenesis over time alongside the ‘classic’ markers 
that are commonly used in the field..
Reviewer II: Please explain why factors were selected for 
RT-PCR on the basis that they are soluble proteins.
Authors: This decision was made in order to remove 
possible differences in the data as a result of changes to 
turnover (including internalisation) and the shedding of 
membrane bound proteins (in particular in response to 
load) which may further cloud the differences between 
the media protein content and mRNA levels as determined 
by RT-PCR.
Reviewer II: What further experiments do you suggest to 
investigate the role of NO in load-induced chondrogenesis?
Authors: This is something we are really excited about. 
The first thing to establish is how load and NO are related. 
In order to do that, we would load in the presence of an 
NOS blocker. If NO is involved in mechano-transduction 
then the block may disrupt chondrogenesis. If blocking NO 
does not affect chondrogenesis and NO is being produced 
as part of a separate process, the benefit of blocking NO 
production on chondrogenesis could be investigated, to see 
if you can get a better chondrogenic outcome.
Editor’s Note: Scientific Editor in charge of the paper: 
Chris Evans.
